All resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog
Can Borrowing Historical Data Ever Increase Power?
Recent papers show that Bayesian borrowing of historical control data cannot increase power under standard type 1 error control. Kert Viele argues that the answer depends on what “type 1 error control” actually controls, and that when the goal is fewer false positive conclusions, borrowing on the control arm can be the better choice.

Podcast Episode
85: Can Borrowing Ever Increase Power?
In this episode of "In the Interim…", Dr. Kert Viele, Director of Research at Berry Consultants, takes up a requested topic: published results showing that Bayesian borrowing of historical control data cannot increase power when type I error is controlled.

Podcast Episode
84: Mailbag: Learning Healthcare, Multiplicities, and the Pace of Innovation
In this mailbag episode of "In the Interim…", Dr. Scott Berry answers two listener questions and weighs in on the pace of innovation in clinical trial science.
News and Events
2026 Deming Conference
At the 2026 Deming Conference in Atlantic City, New Jersey (December 9–11), Dr. Don Berry will deliver a keynote presentation titled “Bayesian Adaptive Clinical Trials: From Bandit Problems to Real-World Innovation.”

Podcast Episode
83: Reflecting on EMA Reflections on Platform Trials
In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele, Director of Research at Berry Consultants, review the European Medicines Agency's draft reflection paper on methodological aspects in confirmatory platform trials.

Podcast Episode
82: Statistical Methodology Groups in the Pharmaceutical Industry
In this episode of "In the Interim…", Scott Berry is joined by Jenny Devenport and Kaspar Rufibach of Merck Group, co-authors of the EFSPI Statistical Methodology Leaders paper "Statistical Methodology Groups in the Pharmaceutical Industry," and May Mo of Amgen, a co-author of the commentary on the paper from the Statistical Innovation Community, an ASA Biopharmaceutical working group.
No results found.
There are no results with this criteria. Try changing your search.
